Novartis AG
NVS News Today: Stay Updated with the Latest Novartis AG News in Real Time
Find NVS news now at Meyka AI. Stay informed with the latest Novartis AG stocks updates, including price news, market analysis, and expert insights.
Ypsomed Holding AG (YPSN.SW) Slips 1.5% Ahead of May 20 Earnings
YPSN.SW stock falls 1.5% to CHF298.4 on SIX ahead of earnings announcement May 20. Medical device maker faces valuation pressure.
Molecular Partners AG (MOLN.SW) Drops 4.14% After Earnings Announcement
MOLN.SW stock falls 4.14% to CHF 3.01 on SIX after earnings. Biotech firm faces profitability challenges with negative EPS of -1.65.
ROG.SW stock gains 0.5% on May 13 as Roche Holding AG trades actively
ROG.SW stock price at CHF322.3, up 0.5% today. Roche Holding AG trades 778,976 shares on SIX exchange with neutral B+ rating.
NOVN.SW stock gains 2.24% on May 12 as healthcare sector rallies
Novartis AG (NOVN.SW) closes at CHF 115.90 with 2.24% gain on SIX exchange. Healthcare stock shows strong momentum.
MOLN.SW Stock Falls 1.85% Before May 12 Earnings Announcement
MOLN.SW drops 1.85% to CHF 3.18 on SIX ahead of May 12 earnings. Biotech stock shows mixed signals with C+ rating.
MOLN.SW Stock Falls 1.5% on May 8 as Earnings Loom
MOLN.SW stock drops 1.5% to CHF3.23 ahead of May 12 earnings. Biotech firm faces profitability challenges with negative EPS of -1.65.
ROG.SW Stock Rises 0.5% on May 8, 2026 as Roche Holds Steady
ROG.SW stock gained 0.5% to CHF322.3 on May 8, 2026. Roche Holding AG trades on SIX with a market cap of CHF256.6B and strong healthcare fundamentals.
NOVN.SW Stock Falls 2% on May 7, 2026 as Healthcare Sector Weakens
NOVN.SW stock dropped 2.02% to CHF 113.30 on May 7, 2026. Novartis AG trades on SIX with a B+ rating and strong fundamentals despite market headwinds.
Bayer Stock May 7: $2.45B Perfuse Deal Signals Pharma Shift
Bayer acquires Perfuse Therapeutics for $2.45B to strengthen ophthalmology pipeline with PER-001 eye implant candidate.